This National Ebola Training and Education Center course discusses the assessment, management, and placement of persons suspected to have Ebola and Other Special Pathogens.
.This course facilitates learners to describe pathogen-related factors that may warrant treatment in a biocontainment unit and to distinguish between concepts of infectious, communicable, and hazardous as they relate to Ebola and other special pathogens of concern. Participants will also be able to describe the clinical presentation of selected special pathogens from the two broad categories: viral hemorrhagic fevers and the highly pathogenic respiratory viruses.
The University of Nebraska Medical Center in Omaha confirmed Saturday that the unidentified person was being monitored in a secure facility not accessible to the public or other patients.
By preventing bioengineered microalgae from growing outside the lab, researchers have reduced the risk of the genetically modified organisms escaping into the wild.
Half-facepiece reusable elastomeric respirators are an effective and viable option for protecting health care workers from exposure to airborne transmissible contaminants or infectious agents during day-to-day work or with a sudden or rapid influx of patients, such as during a public health emergency.
During the study, the use of personal protective equipment after the occurrence of Middle East respiratory syndrome (MERS) infections compared with the period before MERS infections increased dramatically from 2,947.4 to 10,283.9 per 1,000 patient-days for surgical masks and from 22 to 232 per 1,000 patient-days for N95 masks.
For more than 40 years, the British Royal Air Force has maintained an aeromedical evacuation facility, the Deployable Air Isolator Team (DAIT), to transport patients with possible or confirmed highly infectious diseases to the United Kingdom. Currently, no UK-published guidelines exist on how to transfer such patients.
Their new method prevents genetically modified cyanobacteria from surviving outside of their test environment, enabling ways to more safely research the effects of genetically modified organisms (GMOs).
The Johns Hopkins Biocontainment Unit is one of 10 regional centers across the country designed to respond to outbreaks of highly infectious diseases or bioterrorism attacks.